Red Light Therapy for Proud Flesh in Horses: Why the Timing Relative to Granulation Matters More Than the Light
Share
Proud flesh is not infection, and it is not a disease — it is the wound healing process overshooting. The granulation tissue that normally fills a wound bed and provides the surface for new skin to grow across has, in this case, kept growing beyond the wound edges, creating a raised, pink, bumpy mass that physically blocks the skin from closing. Understanding this matters, because it determines what any therapy — including red light therapy for horses — can and cannot do. Red light therapy does not shrink or remove proud flesh. Once the tissue has formed, the treatment is veterinary: trimming, topical corticosteroids, and appropriate wound management.
The second point this guide addresses is timing. If red light therapy has any legitimate role in proud flesh situations, it is before the tissue forms — not after. Photobiomodulation (PBM) research supports its potential to help modulate inflammation and support orderly tissue repair during normal wound healing. Since proud flesh is fundamentally a disorder of disorganised healing — the wound stuck in the proliferative phase and unable to transition to remodelling — supporting orderly healing during the earlier stages is where light may contribute. Our wider guide to red light therapy for horse wounds covers the broader wound-healing picture this sits inside.
And the third point is anatomical: proud flesh overwhelmingly develops on the lower limb — below the knee or hock — and there are specific reasons why. The distal limb has minimal soft tissue coverage, limited blood supply, and constant motion from joint and tendon movement. In lower limb wounds, approximately 70 percent of healing relies on epithelialisation rather than wound contraction, which makes the process slower and more vulnerable to disruption. Knowing why the lower limb is different helps you understand why prompt veterinary wound care — not any adjunct therapy — is the decisive factor in whether proud flesh develops in the first place.
The Short Answer
Red light therapy does not treat proud flesh. Once exuberant granulation tissue has formed, the established treatments are surgical debridement, topical corticosteroids, and proper wound management.
Where light may have a role: supporting orderly wound healing before proud flesh develops, or after a vet has trimmed the tissue and reset the wound bed — by encouraging normal tissue repair and epithelialisation alongside the vet's wound management plan.
What determines the outcome: prompt veterinary wound assessment, proper debridement, infection control, appropriate bandaging, and movement restriction. These are not things a light device can substitute for.
What Proud Flesh Actually Is — and Why It Will Not Respond to Light
Normal wound healing in four stages
Understanding proud flesh requires understanding the healing process it disrupts. Normal wound healing proceeds through four overlapping stages:
| Stage | What happens | Approximate timing |
|---|---|---|
| 1. Haemostasis | Blood clotting stops the bleeding and forms a wound matrix | Minutes to hours |
| 2. Inflammation | Immune cells clear debris and bacteria; swelling and redness occur | Hours to days |
| 3. Proliferation | Granulation tissue fills the wound bed; new blood vessels form; epithelial cells begin migrating across the surface | Days to weeks |
| 4. Remodelling | Collagen reorganises from immature type III to mature type I; the wound gains tensile strength; scar tissue forms | Weeks to months (up to 1–2 years for full maturation) |
In a normally healing wound, granulation tissue stops growing once it has filled the defect to the level of the surrounding skin. Epithelial cells (keratinocytes) then migrate laterally across that flat surface to close the wound, while myofibroblasts within the granulation tissue pull the wound edges together through contraction.
Where proud flesh goes wrong
Proud flesh develops when the proliferative phase does not stop. The granulation tissue continues growing beyond skin level, forming a raised, pink, highly vascularised mass. Research on equine exuberant granulation tissue (EGT) shows that it is characterised by tissue that is stuck in the proliferative phase — unable to transition into the remodelling phase where collagen matures and the wound resolves. Studies on collagen composition in naturally occurring EGT confirm that it reflects tissue immaturity: it contains excessive type III collagen (associated with early granulation) relative to mature type I collagen, indicating the normal collagen transition has stalled.
Why the raised tissue blocks healing
Epithelial cells — the skin cells that close a wound — can only migrate laterally. They cannot climb. When granulation tissue rises above the wound edges, it creates a physical barrier that keratinocytes cannot cross. The mushroom-like shape also disrupts the contractile activity of myofibroblasts. The result is that both wound contraction and epithelialisation stall — sometimes completely.
This is why proud flesh does not resolve on its own in most cases. The tissue must be trimmed back to skin level — surgically, with a scalpel — to restore the flat surface that epithelial cells require to migrate across. Granulation tissue lacks nerve endings, so this trimming is painless, though it bleeds freely because the tissue is heavily vascularised.
Why light cannot solve this
Red light therapy works by stimulating cellular processes — ATP production, inflammatory modulation, collagen activity. It does not physically remove tissue. Once a mass of exuberant granulation tissue exists above the wound edges, no amount of photon delivery will reduce its height, reorganise its disordered collagen, or restore the flat wound bed that epithelial cells need. The problem is mechanical and structural, not a deficit of cellular energy. A scalpel solves it. Light does not.
Why the Lower Limb Is Where Proud Flesh Happens
Proud flesh can technically develop on any wound healing by second intention (i.e. not sutured closed), but it overwhelmingly occurs on the distal limb — below the knee or hock. There are specific anatomical reasons for this, and they explain why lower limb wounds in horses are a fundamentally different healing challenge from body wounds.
| Factor | Lower limb | Body (trunk) |
|---|---|---|
| Soft tissue coverage | Minimal — skin sits close to bone, tendon, and ligament | Substantial subcutaneous fat and muscle |
| Primary healing mechanism | ~70% epithelialisation, ~30% contraction | Primarily contraction — wound edges pull together |
| Blood supply | Relatively poor | Rich vascular bed |
| Motion | Constant — joint and tendon movement tears healing tissue | Relatively stable |
| Contamination risk | High — close to the ground | Lower |
| Proud flesh risk | High | Rare |
The practical consequence is straightforward: body wounds in horses heal rapidly, primarily through contraction, and rarely develop exuberant granulation tissue. Limb wounds heal slowly, depend heavily on the fragile process of epithelialisation, and are prone to exactly the complications — infection, motion-induced disruption, hypoxia — that cause the proliferative phase to overshoot. This is why every lower limb wound on a horse deserves prompt veterinary assessment, not a wait-and-see approach.
The bandaging paradox: bandaging is often necessary to protect lower limb wounds from contamination and further trauma. But research also shows that occlusive bandaging can create a warm, moist, hypoxic environment that promotes excessive angiogenesis and granulation tissue formation. This is why bandaging protocols for lower limb wounds must follow your vet's guidance precisely — the type of dressing, the frequency of changes, and when to transition to open-air management all matter.
The Honest Place for Red Light Therapy in Wound Healing
What PBM research supports in wound healing generally
The photobiomodulation literature on wound healing — primarily from laboratory animal models and human clinical studies — supports several mechanisms that are relevant to orderly tissue repair:
- Modulation of inflammation. PBM appears to help regulate the inflammatory phase, potentially helping wounds transition from inflammation to proliferation more efficiently. Since proud flesh develops partly due to a prolonged and inefficient inflammatory phase, this is theoretically relevant.
- Support for fibroblast activity and collagen organisation. Research shows PBM can stimulate fibroblast proliferation and migration, and may influence collagen deposition patterns. Studies in animal models have shown that PBM-treated wounds demonstrate earlier transition to the remodelling phase, with more organised collagen fibre alignment compared to controls.
- Promotion of epithelialisation. Some evidence suggests PBM supports keratinocyte migration, which is the critical process for wound closure — and the process that proud flesh physically blocks.
- Enhancement of angiogenesis. PBM supports new blood vessel formation, which is necessary for healthy granulation tissue — though in the context of proud flesh, excessive angiogenesis is part of the problem, which is an important nuance.
The critical nuance for proud flesh
Here is the tension that honest guidance has to acknowledge: the mechanisms PBM supports — fibroblast activity, angiogenesis, granulation tissue formation — are the same processes that overshoot in proud flesh.
If a wound is healing normally, supporting those processes is beneficial. But if a wound is already trending toward exuberant granulation — if the proliferative phase is already overshooting — then stimulating more fibroblast activity and angiogenesis is the opposite of what you want.
This is why the timing question is not academic. Applying PBM to a clean, early-stage wound under proper veterinary management is a different proposition from applying it to a wound that is already producing excessive granulation tissue. The first may support orderly healing. The second may, in theory, make things worse — though direct equine evidence on this specific point is lacking.
The guiding principle: if you are considering red light therapy for a wound that is at risk of proud flesh — any lower limb wound healing by second intention — the decision belongs to your vet. They can assess whether the wound is in a phase where supportive PBM is appropriate, or whether the proliferative activity is already excessive and stimulation would be counterproductive. This is not a decision to make based on a blog article.
When Red Light Therapy May Have a Role — and When It Does Not
| Scenario | Role for red light therapy? | What to do instead |
|---|---|---|
| Active proud flesh — raised tissue above wound edges | No. Light does not remove or shrink exuberant granulation tissue | Veterinary debridement (scalpel trimming), topical corticosteroids (e.g. Panalog), appropriate bandaging |
| Early wound (first days) — granulation not yet formed | Possibly, with vet approval. May support orderly inflammatory transition | Vet assessment, wound cleaning, appropriate dressing, infection control |
| Post-debridement — vet has trimmed proud flesh, wound bed is level | Possibly, with vet approval. May support epithelialisation on the reset wound bed | Follow vet's post-trimming bandaging protocol, monitor for recurrence |
| Clean wound with healthy granulation tissue — not yet overgrown | Possibly, with vet approval. May support normal tissue repair alongside proper wound care | Maintain wound hygiene, appropriate bandaging, minimise motion |
| Wound already trending toward excessive granulation | Caution. Stimulating fibroblast activity and angiogenesis may be counterproductive | Vet reassessment, topical corticosteroids, bandaging adjustment |
If your vet agrees to supportive PBM alongside wound care
If your veterinarian has assessed the wound, determined it is in a phase where supportive photobiomodulation is appropriate, and agreed to include it in the wound management plan, the practical application is straightforward. For lower limb wounds, our red light therapy leg boots are designed to wrap the cannon, fetlock, and lower leg area where these wounds most commonly occur. Sessions of 10–15 minutes per area, using the dual wavelengths standard in equine PBM (660 nm red for surface tissue; 810–850 nm near-infrared for deeper penetration), applied daily during the active healing phase.
Do not apply a red light device to a wound without your vet's knowledge. This is not general caution — it is specific to the proud flesh context. If the wound is already trending toward excessive granulation, stimulating cellular activity without veterinary oversight could work against the management plan. Your vet needs to know what you are applying to the wound so they can assess healing accurately and adjust their approach if needed.
What Actually Prevents Proud Flesh
Because proud flesh is far easier to prevent than to treat once established, the preventive measures deserve as much attention as any discussion of adjunct therapy. These are the interventions with real evidence behind them — and they are all veterinary, not device-related.
The five factors that determine whether proud flesh develops
- Prompt veterinary assessment. Any wound on the lower limb that is too large or too deep to suture should be assessed by a vet within 24 hours. Delay is where problems begin — infection sets in, the inflammatory phase extends, and the cascade toward exuberant granulation starts.
- Proper debridement and cleaning. Removing foreign material, bone fragments, and dead tissue from the wound bed is critical. Retained debris causes chronic inflammation — the primary driver of proud flesh formation.
- Infection control. Contaminated wounds are significantly more prone to proud flesh. Appropriate antimicrobial management (per vet guidance — not over-the-counter wound sprays) reduces the inflammatory stimulus that feeds excessive granulation.
- Appropriate bandaging. Bandaging protects the wound and can apply gentle pressure that helps control granulation tissue height. But the type of dressing, the frequency of changes, and when to stop bandaging are veterinary decisions. Incorrect bandaging — particularly occlusive dressings left on too long — can promote the warm, hypoxic conditions that favour proud flesh.
- Motion restriction. Movement at the wound site tears healing tissue and triggers renewed inflammation. Stall rest, reduced turnout, and in severe cases casting or splinting may be recommended to protect the wound bed during the critical proliferative phase.
The topical product warning
Many horse owners apply topical wound products — nitrofurazone, hydrogen peroxide, betadine, or home remedies — believing they help. Many of these agents are actually caustic to healthy tissue, damaging the granulation bed and epithelial cells and delaying healing. The AAEP and veterinary wound specialists advise against applying any topical product to a wound until a vet has assessed it. The same principle applies to red light therapy: no device or product should be applied without veterinary guidance, particularly on a wound at risk of proud flesh.
After Debridement: Where Light May Support the Second Chance
When a vet trims proud flesh, they are essentially resetting the wound. The exuberant tissue is cut back to skin level, creating a flat wound bed that epithelial cells can migrate across. The wound then has a second opportunity to heal normally — if the conditions are right.
This post-debridement window is where supportive PBM has its most plausible role. The wound bed is clean and level. The healing process is restarting. And the goal is to support orderly tissue repair — fibroblast activity, collagen organisation, epithelialisation — without the proliferative phase overshooting again.
Practically, this means:
- Follow the vet's post-trimming wound management plan first and completely. Bandaging protocol, topical treatment (often a corticosteroid to suppress re-growth), and movement restriction are the primary interventions.
- Ask the vet whether supportive PBM is appropriate alongside their plan. If they agree, apply sessions of 10–15 minutes daily to the wound area using a device that can be positioned over the bandaged or unbandaged area as the vet directs.
- Monitor closely for recurrence. Proud flesh commonly recurs if the underlying factors — infection, motion, bandaging issues — are not controlled. Report any tissue rising above wound level to your vet immediately.
For understanding how red and near-infrared wavelengths interact with tissue at different depths — relevant to wound healing where you are targeting surface epithelialisation and deeper tissue repair simultaneously — our wavelength penetration depth guide covers the science in detail.
The honest framing: there is no controlled equine study demonstrating that red light therapy after proud flesh debridement improves outcomes compared to proper wound management alone. The role described here is based on the general PBM wound-healing literature and clinical reasoning — not on proven efficacy for this specific situation. Your vet's wound management plan is what determines the outcome. Light is, at best, a modest adjunct around the edges.
Conclusion: The Scalpel First, the Light Around the Edges
Proud flesh is a mechanical and structural problem — exuberant granulation tissue that has overgrown the wound edges and physically blocked the skin from closing. It is not an energy deficit that more cellular stimulation will solve. Once the tissue has formed, the treatment is veterinary: a scalpel to trim it back to skin level, topical corticosteroids to suppress re-growth, appropriate bandaging, and the motion restriction and infection control that determine whether it recurs.
Red light therapy does not treat proud flesh. It does not shrink it, remove it, or reverse the disorganised collagen and excessive angiogenesis that characterise exuberant granulation tissue. And there is a specific reason to be cautious about applying it to a wound that is already trending toward excessive granulation: the mechanisms PBM supports — fibroblast activity, angiogenesis, cellular proliferation — are the same processes that are already overshooting.
Where light may have a modest, supporting place is in the phases where orderly healing is the goal: early wound management before proud flesh develops, or after a vet has debrided the tissue and reset the wound bed. In both cases, the vet's wound management plan is doing the work. The light is around the edges — and the question to ask your vet is not "should I use red light therapy?" but "is the wound healing the way it should, and what does the tissue look like this week?"
Get the vet to the wound early. Keep it clean. Control the infection. Restrict the motion. And if the tissue overshoots, let the scalpel do what the scalpel does.
Frequently Asked Questions
Can red light therapy help with proud flesh on a horse?
Not in the way most owners hope. Once exuberant granulation tissue has formed — the pink, bumpy mass that rises above the wound edges — the established treatments are surgical debridement (trimming the tissue back to skin level with a scalpel), topical corticosteroids to suppress further overgrowth, and appropriate bandaging. Red light therapy does not remove or shrink existing proud flesh. Where photobiomodulation may have a legitimate supporting role is earlier in the wound healing process — before proud flesh develops — by supporting orderly tissue repair, collagen organisation, and epithelialisation. The distinction matters: if you are dealing with an active proud flesh problem, call your vet for debridement. If you are managing a clean wound on the lower limb and want to support normal healing alongside proper wound care, that is where light may have a place — with your vet's agreement.
What causes proud flesh in horses?
Proud flesh — exuberant granulation tissue — develops when the proliferative phase of wound healing overshoots. Normal granulation tissue fills the wound bed until it is level with the surrounding skin, at which point epithelial cells migrate across the surface to close the wound. In proud flesh, the granulation tissue continues growing beyond that level, creating a raised mass that physically prevents epithelial cells from migrating across it. Horses are more prone to this than other species, and wounds on the lower limb — below the knee or hock — are the most common site because the distal limb has minimal soft tissue coverage, limited blood supply, and constant motion from joint and tendon movement. In lower limb wounds, approximately 70 percent of healing relies on epithelialisation rather than wound contraction, which makes any disruption to that process particularly consequential. Contributing factors include wound infection, excessive movement, inappropriate bandaging, foreign material in the wound, and the application of caustic topical products that damage healthy tissue.
Can red light therapy prevent proud flesh from forming?
There is no direct evidence that red light therapy prevents proud flesh formation in horses. Proud flesh develops due to a prolonged and inefficient inflammatory phase that causes the proliferative phase to overshoot — a process driven by factors such as wound infection, excessive motion, hypoxia, and anatomical limitations of the lower limb. Red light therapy does not address those mechanical and biological drivers. What photobiomodulation research does support is that it may help modulate inflammation and support orderly tissue repair during normal wound healing — and since proud flesh is fundamentally a disorder of disorganised wound healing, supporting the normal process may be indirectly relevant. But this is speculative and should not be treated as a prevention strategy. The proven measures for preventing proud flesh are prompt veterinary wound assessment, proper debridement, infection control, appropriate bandaging, and minimising motion at the wound site.
Should I use red light therapy on a wound before or after proud flesh is trimmed?
After, if your vet agrees — and only once the wound bed has been properly managed. When a vet trims proud flesh, they cut the exuberant granulation tissue back to skin level with a scalpel, creating a clean, level wound bed that epithelial cells can migrate across. This is essentially resetting the wound to a state where normal healing can resume. Supporting that renewed healing process is where red light therapy may have a modest role — by encouraging orderly tissue repair and epithelialisation on the now-level wound bed. But the vet's post-trimming wound management plan — bandaging protocol, topical treatment, infection control, movement restriction — is what determines whether the proud flesh recurs. Red light therapy does not replace any of those steps. Ask your vet whether supportive photobiomodulation has a place alongside their wound management plan after debridement.
Why does proud flesh mostly happen on a horse's lower legs?
Several anatomical factors combine to make the distal limb — below the knee or hock — the primary site for exuberant granulation tissue. First, the lower limb has very little soft tissue coverage: skin sits close to bone, tendon, and ligament with minimal subcutaneous fat or muscle, which means there is not enough loose skin to contract and close the wound the way body wounds do. Second, blood supply to the distal limb is relatively poor compared to the trunk, which can lead to a hypoxic wound environment that promotes excessive angiogenesis and prolonged inflammation. Third, constant motion from joint and tendon movement disrupts the healing tissue bed, tearing newly forming granulation tissue and epithelial cells and triggering further inflammatory response. And fourth, lower limb wounds are close to the ground and harder to keep clean, increasing the risk of contamination and infection. The result is that in lower limb wounds, approximately 70 percent of healing depends on epithelialisation rather than contraction — and anything that disrupts epithelialisation, including a mass of granulation tissue growing above skin level, can stall the entire healing process.
